1	Clonal	Clonal	B-NP	JJ	O	2	NMOD
2	strains	strain	I-NP	NNS	O	0	ROOT
3	of	of	B-PP	IN	O	2	NMOD
4	Pseudomonas	Pseudomonas	B-NP	NN	O	5	NMOD
5	aeruginosa	aeruginosa	I-NP	NN	O	3	PMOD
6	in	in	B-PP	IN	O	2	NMOD
7	paediatric	paediatric	B-NP	JJ	O	9	AMOD
8	and	and	I-NP	CC	O	9	AMOD
9	adult	adult	I-NP	JJ	O	12	NMOD
10	cystic	cystic	I-NP	JJ	O	12	NMOD
11	fibrosis	fibrosis	I-NP	NN	O	12	NMOD
12	units	unit	I-NP	NNS	O	6	PMOD
13	.	.	O	.	O	2	P

1	Despite	Despite	B-PP	IN	O	24	VMOD
2	recent	recent	B-NP	JJ	O	3	NMOD
3	reports	report	I-NP	NNS	O	1	PMOD
4	of	of	B-PP	IN	O	3	NMOD
5	clonal	clonal	B-NP	JJ	O	6	NMOD
6	strains	strain	I-NP	NNS	O	4	PMOD
7	of	of	B-PP	IN	O	6	NMOD
8	Pseudomonas	Pseudomonas	B-NP	NN	O	9	NMOD
9	aeruginosa	aeruginosa	I-NP	NN	O	7	PMOD
10	in	in	B-PP	IN	O	6	NMOD
11	cystic	cystic	B-NP	JJ	B-protein	16	NMOD
12	fibrosis	fibrosis	I-NP	NN	I-protein	16	NMOD
13	(	(	O	(	I-protein	16	NMOD
14	CF	CF	B-NP	NN	I-protein	16	NMOD
15	)	)	O	)	I-protein	16	NMOD
16	units	unit	B-NP	NNS	I-protein	10	PMOD
17	,	,	O	,	O	24	P
18	the	the	B-NP	DT	O	19	NMOD
19	need	need	I-NP	NN	O	24	SUB
20	for	for	B-PP	IN	O	19	NMOD
21	routine	routine	B-NP	JJ	O	23	NMOD
22	microbiological	microbiological	I-NP	JJ	O	23	NMOD
23	surveillance	surveillance	I-NP	NN	O	20	PMOD
24	remains	remain	B-VP	VBZ	O	0	ROOT
25	contentious	contentious	B-ADJP	JJ	O	24	PRD
26	.	.	O	.	O	24	P

1	Sputum	Sputum	B-NP	NNP	O	2	SUB
2	was	be	B-VP	VBD	O	0	ROOT
3	collected	collect	I-VP	VBN	O	2	VC
4	prospectively	prospectively	B-ADVP	RB	O	3	VMOD
5	from	from	B-PP	IN	O	3	VMOD
6	productive	productive	B-NP	JJ	O	7	NMOD
7	patients	patient	I-NP	NNS	O	5	PMOD
8	attending	attend	B-VP	VBG	O	7	NMOD
9	the	the	B-NP	DT	O	15	NMOD
10	regional	regional	I-NP	JJ	O	13	AMOD
11	paediatric	paediatric	I-NP	JJ	O	13	AMOD
12	and	and	I-NP	CC	O	13	AMOD
13	adult	adult	I-NP	JJ	O	15	NMOD
14	CF	CF	I-NP	NN	O	15	NMOD
15	units	unit	I-NP	NNS	O	8	OBJ
16	in	in	B-PP	IN	O	15	NMOD
17	Brisbane	Brisbane	B-NP	NNP	O	19	NMOD
18	,	,	O	,	O	19	P
19	Australia	Australia	B-NP	NNP	O	16	PMOD
20	.	.	O	.	O	2	P

1	All	All	B-NP	DT	O	4	NMOD
2	P.	P.	I-NP	NNP	O	4	NMOD
3	aeruginosa	aeruginosa	I-NP	NN	O	4	NMOD
4	isolates	isolate	I-NP	NNS	O	5	SUB
5	were	be	B-VP	VBD	O	0	ROOT
6	typed	type	I-VP	VBN	O	5	VC
7	using	use	B-VP	VBG	O	5	VMOD
8	pulsed-field	pulsed-field	B-NP	JJ	O	10	NMOD
9	gel	gel	I-NP	NN	O	10	NMOD
10	electrophoresis	electrophoresis	I-NP	NN	O	7	OBJ
11	.	.	O	.	O	5	P

1	Spirometry	Spirometry	B-NP	NN	O	9	NMOD
2	,	,	O	,	O	9	P
3	anthropometrics	anthropometric	B-NP	NNS	O	9	NMOD
4	,	,	O	,	O	9	P
5	hospitalisations	hospitalisation	B-NP	NNS	O	9	NMOD
6	and	and	O	CC	O	9	NMOD
7	antibiotic	antibiotic	B-NP	JJ	O	9	NMOD
8	sensitivity	sensitivity	I-NP	NN	O	9	NMOD
9	data	datum	I-NP	NNS	O	10	SUB
10	were	be	B-VP	VBD	O	0	ROOT
11	recorded	record	I-VP	VBN	O	10	VC
12	.	.	O	.	O	10	P

1	The	The	B-NP	DT	O	5	NMOD
2	first	first	I-NP	JJ	O	5	NMOD
3	100	100	I-NP	CD	O	5	NMOD
4	sputum	sputum	I-NP	NN	O	5	NMOD
5	samples	sample	I-NP	NNS	O	14	SUB
6	(	(	O	(	O	13	DEP
7	first	first	B-NP	JJ	O	9	NMOD
8	50	50	I-NP	CD	O	9	NMOD
9	patients	patient	I-NP	NNS	O	13	DEP
10	at	at	B-PP	IN	O	9	NMOD
11	each	each	B-NP	DT	O	12	NMOD
12	clinic	clinic	I-NP	NN	O	10	PMOD
13	)	)	O	)	O	5	NMOD
14	harboured	harbour	B-VP	VBD	O	0	ROOT
15	163	163	B-NP	CD	O	16	NMOD
16	isolates	isolate	I-NP	NNS	O	14	OBJ
17	of	of	B-PP	IN	O	16	NMOD
18	P.	P.	B-NP	NNP	O	19	NMOD
19	aeruginosa	aeruginosa	I-NP	NNP	O	17	PMOD
20	.	.	O	.	O	14	P

1	A	A	B-NP	DT	O	2	NMOD
2	total	total	I-NP	NN	O	6	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	39	39	B-NP	CD	O	5	NMOD
5	patients	patient	I-NP	NNS	O	3	PMOD
6	shared	share	B-VP	VBD	O	17	VMOD
7	a	a	B-NP	DT	O	9	NMOD
8	common	common	I-NP	JJ	O	9	NMOD
9	strain	strain	I-NP	NN	O	6	OBJ
10	(	(	O	(	O	13	DEP
11	pulsotype	pulsotype	B-NP	NN	O	13	DEP
12	2	2	I-NP	CD	O	11	NMOD
13	)	)	O	)	O	9	NMOD
14	,	,	O	,	O	6	P
15	20	20	B-NP	CD	O	16	NMOD
16	patients	patient	I-NP	NNS	O	17	SUB
17	shared	share	B-VP	VBD	O	0	ROOT
18	a	a	B-NP	DT	O	19	NMOD
19	strain	strain	I-NP	NN	O	17	OBJ
20	with	with	B-PP	IN	O	17	VMOD
21	at	at	B-NP	IN	O	28	NMOD
22	least	least	I-NP	JJS	O	21	AMOD
23	one	one	I-NP	CD	O	21	AMOD
24	other	other	I-NP	JJ	O	25	NMOD
25	patient	patient	I-NP	NN	O	28	NMOD
26	and	and	O	CC	O	28	NMOD
27	41	41	B-NP	CD	O	28	NMOD
28	patients	patient	I-NP	NNS	O	29	SUB
29	harboured	harbour	B-VP	VBD	O	20	SBAR
30	unique	unique	B-NP	JJ	O	31	NMOD
31	strains	strain	I-NP	NNS	O	29	OBJ
32	.	.	O	.	O	17	P

1	Eight	Eight	B-NP	CD	O	2	NMOD
2	patients	patient	I-NP	NNS	O	3	SUB
3	shared	share	B-VP	VBD	O	0	ROOT
4	a	a	B-NP	DT	O	5	NMOD
5	strain	strain	I-NP	NN	O	3	OBJ
6	identical	identical	B-ADJP	JJ	O	5	NMOD
7	to	to	B-PP	TO	O	6	AMOD
8	a	a	B-NP	DT	O	13	NMOD
9	previously	previously	I-NP	RB	O	10	AMOD
10	reported	report	I-NP	VBN	O	13	NMOD
11	Australian	Australian	I-NP	JJ	O	13	NMOD
12	transmissible	transmissible	I-NP	JJ	O	13	NMOD
13	strain	strain	I-NP	NN	O	7	PMOD
14	(	(	O	(	O	17	DEP
15	pulsotype	pulsotype	B-NP	NN	O	17	DEP
16	1	1	I-NP	CD	O	15	NMOD
17	)	)	O	)	O	13	NMOD
18	.	.	O	.	O	3	P

1	Compared	Compare	B-PP	VBN	O	12	VMOD
2	with	with	B-PP	IN	O	1	PMOD
3	the	the	B-NP	DT	O	6	NMOD
4	unique	unique	I-NP	JJ	O	6	NMOD
5	strain	strain	I-NP	NN	O	6	NMOD
6	group	group	I-NP	NN	O	2	PMOD
7	,	,	O	,	O	12	P
8	patients	patient	B-NP	NNS	O	12	SUB
9	harbouring	harbour	B-VP	VBG	O	8	NMOD
10	pulsotype	pulsotype	B-NP	NN	O	9	OBJ
11	2	2	I-NP	CD	O	10	NMOD
12	were	be	B-VP	VBD	O	0	ROOT
13	younger	young	B-ADJP	JJR	O	12	PRD
14	and	and	O	CC	O	12	VMOD
15	had	have	B-VP	VBD	O	12	VMOD
16	poorer	poor	B-NP	JJR	O	18	NMOD
17	lung	lung	I-NP	NN	O	18	NMOD
18	function	function	I-NP	NN	O	15	OBJ
19	.	.	O	.	O	12	P

1	Treatment	Treatment	B-NP	NN	O	2	NMOD
2	requirements	requirement	I-NP	NNS	O	3	SUB
3	were	be	B-VP	VBD	O	0	ROOT
4	similar	similar	B-ADJP	JJ	O	3	PRD
5	in	in	B-PP	IN	O	4	AMOD
6	these	these	B-NP	DT	O	8	NMOD
7	two	two	I-NP	CD	O	8	NMOD
8	groups	group	I-NP	NNS	O	5	PMOD
9	,	,	O	,	O	3	P
10	as	as	B-SBAR	IN	O	3	VMOD
11	were	be	B-VP	VBD	O	10	SBAR
12	the	the	B-NP	DT	O	13	NMOD
13	rates	rate	I-NP	NNS	O	11	PRD
14	of	of	B-PP	IN	O	13	NMOD
15	multiresistance	multiresistance	B-NP	NN	O	14	PMOD
16	.	.	O	.	O	3	P

1	In	In	B-PP	IN	O	8	VMOD
2	conclusion	conclusion	B-NP	NN	O	1	PMOD
3	,	,	O	,	O	8	P
4	59	59	B-NP	CD	O	5	NMOD
5	%	%	I-NP	NN	O	8	SUB
6	of	of	B-PP	IN	O	5	NMOD
7	patients	patient	B-NP	NNS	O	6	PMOD
8	harboured	harbour	B-VP	VBD	O	0	ROOT
9	a	a	B-NP	DT	O	11	NMOD
10	clonal	clonal	I-NP	JJ	O	11	NMOD
11	strain	strain	I-NP	NN	O	8	OBJ
12	,	,	O	,	O	8	P
13	supporting	support	B-VP	VBG	O	8	VMOD
14	the	the	B-NP	DT	O	15	NMOD
15	need	need	I-NP	NN	O	13	OBJ
16	for	for	B-PP	IN	O	15	NMOD
17	routine	routine	B-NP	JJ	O	19	NMOD
18	microbiological	microbiological	I-NP	JJ	O	19	NMOD
19	surveillance	surveillance	I-NP	NN	O	16	PMOD
20	.	.	O	.	O	8	P

1	In	In	B-PP	IN	O	12	VMOD
2	contrast	contrast	B-NP	NN	O	1	PMOD
3	to	to	B-PP	TO	O	2	NMOD
4	previously	previously	B-NP	RB	O	5	AMOD
5	described	describe	I-NP	VBN	O	7	NMOD
6	clonal	clonal	I-NP	JJ	O	7	NMOD
7	strains	strain	I-NP	NNS	O	3	PMOD
8	,	,	O	,	O	12	P
9	the	the	B-NP	DT	O	11	NMOD
10	dominant	dominant	I-NP	JJ	O	11	NMOD
11	pulsotype	pulsotype	I-NP	NN	O	12	SUB
12	was	be	B-VP	VBD	O	0	ROOT
13	indistinguishable	indistinguishable	B-ADJP	JJ	O	12	PRD
14	from	from	B-PP	IN	O	13	AMOD
15	nonclonal	nonclonal	B-NP	JJ	O	16	NMOD
16	strains	strain	I-NP	NNS	O	14	PMOD
17	with	with	B-PP	IN	O	13	AMOD
18	respect	respect	B-NP	NN	O	17	PMOD
19	to	to	B-PP	TO	O	18	NMOD
20	both	both	O	CC	O	24	NMOD
21	colonial	colonial	B-NP	NN	O	22	NMOD
22	morphology	morphology	I-NP	NN	O	24	NMOD
23	and	and	O	CC	O	24	NMOD
24	multiresistance	multiresistance	B-NP	NN	O	19	PMOD
25	.	.	O	.	O	12	P

1	The	The	B-NP	DT	O	3	NMOD
2	clinical	clinical	I-NP	JJ	O	3	NMOD
3	significance	significance	I-NP	NN	O	7	SUB
4	of	of	B-PP	IN	O	3	NMOD
5	clonal	clonal	B-NP	JJ	O	6	NMOD
6	strains	strain	I-NP	NNS	O	4	PMOD
7	remains	remain	B-VP	VBZ	O	0	ROOT
8	uncertain	uncertain	B-ADJP	JJ	O	7	PRD
9	and	and	O	CC	O	7	VMOD
10	requires	require	B-VP	VBZ	O	7	VMOD
11	longitudinal	longitudinal	B-NP	JJ	O	12	NMOD
12	study	study	I-NP	NN	O	10	OBJ
13	.	.	O	.	O	7	P

